2 years ago

Senzo Health Secures $1.8M to Expand its Lab-Accurate Lateral Flow Test Development

  • Senzo Health, a London-based life sciences company developing diagnostic technologies, has raised an additional $1.8 million in funding

  • The company intends to use the funds to expand operations and development efforts

  • Senzo is developing a 10-minute lateral flow test with laboratory-accurate results for a wide range of applications.

      • ProblemLife Sciences

      "making laboratory diagnostics slow or expensive"

      Solution

      "developing a 10-minute lateral flow test with the same accuracy as a laboratory PCR test"

      Covered on